These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28160086)

  • 21. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia.
    Choi I; Yoon SR; Park SY; Kim H; Jung SJ; Kang YL; Lee JH; Lee JH; Kim DY; Lee JL; Park HS; Choi EJ; Lee YS; Kang YA; Jeon M; Seol M; Baek S; Yun SC; Kim HJ; Lee KH
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2065-2076. PubMed ID: 27530969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In utero transplantation for thalassemia.
    Flake AW; Zanjani ED
    Ann N Y Acad Sci; 1998 Jun; 850():300-11. PubMed ID: 9668552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogenic bone narrow transplantation in sickle-cell diseases.
    Simões BP; Pieroni F; Costa T; Barros GN; Darrigo G; Grecco CS; Bernardes JE; Moraes D; Stracieri AB; Cunha R; Rodrigues MC
    Rev Assoc Med Bras (1992); 2016 Oct; 62 Suppl 1():16-22. PubMed ID: 27982320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.
    Chang YJ; Zhao XY; Xu LP; Zhang XH; Wang Y; Han W; Chen H; Wang FR; Mo XD; Zhang YY; Huo MR; Zhao XS; Y K; Liu KY; Huang XJ
    J Hematol Oncol; 2015 Jul; 8():84. PubMed ID: 26156584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The present and future of haploidentical hematopoietic stem cell transplantation in China].
    Mo XD; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jul; 45(7):625-628. PubMed ID: 39231765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
    Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.
    Xu L; Liu Z; Wu Y; Yang X; Cao Y; Li X; Yan B; Li S; Da W; Wu X
    Eur J Med Res; 2018 Mar; 23(1):12. PubMed ID: 29490698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
    Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haploidentical stem cell transplantation in a boy with chronic granulomatous disease.
    Regueiro-García A; Fariña-Nogueira S; Porto-Arceo JÁ; Couselo-Sánchez JM
    Allergol Immunopathol (Madr); 2018; 46(4):385-388. PubMed ID: 29373243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children.
    Bahr TL; Lund T; Sando NM; Orchard PJ; Miller WP
    Bone Marrow Transplant; 2016 Nov; 51(11):1546-1548. PubMed ID: 27376448
    [No Abstract]   [Full Text] [Related]  

  • 33. Availability of related donors for bone marrow transplantation in sickle cell anemia.
    Mentzer WC; Heller S; Pearle PR; Hackney E; Vichinsky E
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):27-9. PubMed ID: 8311169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor-specific antibody prior to haploidentical transplantation.
    Suwantarat N; Iamsirirak P; Chanapai J; Pakakasama S; Andersson BS; Boelens JJ; Anurathapan U; Hongeng S
    Pediatr Blood Cancer; 2024 Nov; 71(11):e31311. PubMed ID: 39228048
    [No Abstract]   [Full Text] [Related]  

  • 35. Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease.
    Hosoya H; Levine J; Abt P; Henry D; Porter DL; Gill S
    Blood Adv; 2018 Mar; 2(5):575-585. PubMed ID: 29535106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database.
    Sun Y; Beohou E; Labopin M; Volin L; Milpied N; Yakoub-Agha I; Piemontese S; Polge E; Houhou M; Huang XJ; Mohty M; Nagler A; Gorin NC;
    Haematologica; 2016 Aug; 101(8):e352-4. PubMed ID: 27081180
    [No Abstract]   [Full Text] [Related]  

  • 37. Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends.
    Shenoy S
    Hematology Am Soc Hematol Educ Program; 2011; 2011():273-9. PubMed ID: 22160045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis.
    Ma YR; Huang XJ; Xu ZL; Liu KY; Chen H; Zhang XH; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Chen Y; Yan CH; Xu LP
    Clin Transplant; 2016 Sep; 30(9):994-1001. PubMed ID: 27292967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.
    Li Pira G; Malaspina D; Girolami E; Biagini S; Cicchetti E; Conflitti G; Broglia M; Ceccarelli S; Lazzaro S; Pagliara D; Meschini A; Bertaina A; Montanari M; Locatelli F
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2056-2064. PubMed ID: 27519279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
    Talano JA; Cairo MS
    Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.